Halozyme Therapeutics Inc (HALO)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$71.58

Buy

$72.69

arrow-down$-0.07 (-0.10%)

Prices updated at 06 Jun 2026, 00:52 EDT

Prices minimum 15 mins delay

Prices in USD

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary p ...

NASDAQ

-4.18%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$72.25 - $70.71
	$82.22 - $51.06
	-
	8,484.39m
	25.10
	-
	1,144,601
	38.63
	2,051,562.26
	0.87
	117.78m
	US40637H1095
	2.85
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.